These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 17559170)
1. Modulation of Valpha19 NKT cell immune responses by alpha-mannosyl ceramide derivatives consisting of a series of modified sphingosines. Shimamura M; Huang YY; Okamoto N; Suzuki N; Yasuoka J; Morita K; Nishiyama A; Amano Y; Mishina T Eur J Immunol; 2007 Jul; 37(7):1836-44. PubMed ID: 17559170 [TBL] [Abstract][Full Text] [Related]
2. Non-reducing end alpha-mannosylated glycolipids as potent activators for invariant Valpha19 TCR-bearing natural killer T cells. Shimamura M Carbohydr Res; 2008 Aug; 343(12):2010-7. PubMed ID: 18445494 [TBL] [Abstract][Full Text] [Related]
3. Synthetic alpha-mannosyl ceramide as a potent stimulant for an NKT cell repertoire bearing the invariant Valpha19-Jalpha26 TCR alpha chain. Okamoto N; Kanie O; Huang YY; Fujii R; Watanabe H; Shimamura M Chem Biol; 2005 Jun; 12(6):677-83. PubMed ID: 15975513 [TBL] [Abstract][Full Text] [Related]
4. Glycolipids with nonreducing end alpha-mannosyl residues that have the potential to activate invariant Valpha19 NKT cells. Shimamura M; Huang YY; Okamoto N; Watanabe Y; Murakami Y; Kinoshita T; Hirabayashi Y; Murakata C; Ito Y; Ogawa T FEBS J; 2007 Jun; 274(11):2921-32. PubMed ID: 17488284 [TBL] [Abstract][Full Text] [Related]
5. Induction of promotive rather than suppressive immune responses from a novel NKT cell repertoire Valpha19 NKT cell with alpha-mannosyl ceramide analogues consisting of the immunosuppressant ISP-I as the sphingosine unit. Shimamura M; Okamoto N; Huang YY; Yasuoka J; Morita K; Nishiyama A; Amano Y; Mishina T Eur J Med Chem; 2006 May; 41(5):569-76. PubMed ID: 16545892 [TBL] [Abstract][Full Text] [Related]
6. MR1-restricted Valpha19i T cells: a second population recognizing lipid antigens? Schümann J; De Libero G Eur J Immunol; 2007 Jul; 37(7):1724-6. PubMed ID: 17587196 [TBL] [Abstract][Full Text] [Related]
7. Glycolipid stimulators for NKT cells bearing invariant V alpha 19-J alpha 33 TCR alpha chains. Shimamura M Mini Rev Med Chem; 2008 Mar; 8(3):285-9. PubMed ID: 18336348 [TBL] [Abstract][Full Text] [Related]
8. Altered production of immunoregulatory cytokines by invariant Valpha19 TCR-bearing cells dependent on the duration and intensity of TCR engagement. Shimamura M; Huang YY; Kobayashi M; Goji H Int Immunol; 2009 Feb; 21(2):179-85. PubMed ID: 19106232 [TBL] [Abstract][Full Text] [Related]
9. Recognition of bacterial glycosphingolipids by natural killer T cells. Kinjo Y; Wu D; Kim G; Xing GW; Poles MA; Ho DD; Tsuji M; Kawahara K; Wong CH; Kronenberg M Nature; 2005 Mar; 434(7032):520-5. PubMed ID: 15791257 [TBL] [Abstract][Full Text] [Related]
10. Regulation of immunological disorders by invariant Vα19-Jα33 TCR-bearing cells. Shimamura M; Huang YY; Goji H; Endo S; Migishima R; Yokoyama M Immunobiology; 2011 Mar; 216(3):374-8. PubMed ID: 20832138 [TBL] [Abstract][Full Text] [Related]
11. Localization of NK1.1(+) invariant Valpha19 TCR(+) cells in the liver with potential to promptly respond to TCR stimulation. Shimamura M; Huang YY; Migishima R; Yokoyama M; Saitoh T; Yamamura T Immunol Lett; 2008 Nov; 121(1):38-44. PubMed ID: 18789972 [TBL] [Abstract][Full Text] [Related]
12. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104 [TBL] [Abstract][Full Text] [Related]
13. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells. Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291 [TBL] [Abstract][Full Text] [Related]
14. CD1, MR1, NKT, and MAIT: evolution and origins of non-peptidic antigen recognition by T lymphocytes. Zajonc DM; Flajnik MF Immunogenetics; 2016 Aug; 68(8):489-90. PubMed ID: 27480412 [No Abstract] [Full Text] [Related]
15. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids. Chang YJ; Huang JR; Tsai YC; Hung JT; Wu D; Fujio M; Wong CH; Yu AL Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10299-304. PubMed ID: 17566107 [TBL] [Abstract][Full Text] [Related]
16. The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition. Sidobre S; Hammond KJ; Bénazet-Sidobre L; Maltsev SD; Richardson SK; Ndonye RM; Howell AR; Sakai T; Besra GS; Porcelli SA; Kronenberg M Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12254-9. PubMed ID: 15304644 [TBL] [Abstract][Full Text] [Related]
17. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide. Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815 [TBL] [Abstract][Full Text] [Related]
18. Recognition and function of Valpha14 NKT cells. Taniguchi M; Nakayama T Semin Immunol; 2000 Dec; 12(6):543-50. PubMed ID: 11145860 [TBL] [Abstract][Full Text] [Related]
19. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Kawano T; Cui J; Koezuka Y; Toura I; Kaneko Y; Motoki K; Ueno H; Nakagawa R; Sato H; Kondo E; Koseki H; Taniguchi M Science; 1997 Nov; 278(5343):1626-9. PubMed ID: 9374463 [TBL] [Abstract][Full Text] [Related]
20. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis. Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]